Effect of Acute Exercise on Cognitive Functions and Blood Markers of Brain Plasticity in Regular Chronic Cannabis Users

ConditionCannabis User
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorUniversity Hospital, Lille

About this trial

The endocannabinoid system (ECS) is a complex endogenous signaling system made up of transmembrane cannabinoid receptors (CB1 and CB2 receptors), their endogenous lipid-derived ligands (the endocannabinoids - eCBs), and enzymes for ligand biosynthesis and degradation. Interestingly, exercise increase plasma AEA, one of the most famous endocannabinoid. This increase could be involved in exercise-induced neurogenesis and other beneficial exercise adaptations. Chronic cannabis use is associated with alteration of ECS activity. The aim of the study is to compare ECS response to exercise between chronic cannabis users and non-users.

Eligibility criteria

Qualifiers

Cannabis consumption > 100 times in lifetime, last exposure < 7 days, and recent exposure > 10 times in the month.

Positive toxicological urine test for ∆-9-THC.

Having a cannabis use disorder according to the CAST.

Negative urine toxicological test for cannabis.

Disqualifiers

Disorders of use of other substances (alcohol, cocaine, opioid, or synthetic drugs).

Alcohol consumption greater than 30g per day (averaged over one week) and/or alcohol abuse the week preceding the visit.

Under medical treatment.

Presence of diagnosed neurological disorders.

Trial design

Treatments tested in this trial

  • activity test

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators